Loading…

A Review of the Patentability of Rosemary-Derived Drugs and Bioactive Compounds

We reviewed the patentability of rosemary-derived drugs and bioactive compounds over the last 20 years and analyzed patent documents related to the rosemary (Rosmarinus officinalis Linné) plant using patent analysis techniques. A total of 12,320 patent documents (patent applications and granted pate...

Full description

Saved in:
Bibliographic Details
Published in:Drugs and drug candidates 2023-03, Vol.2 (1), p.172-188
Main Authors: El Boukhari, Reda, Fatimi, Ahmed
Format: Article
Language:English
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
cited_by cdi_FETCH-LOGICAL-c1121-18a5c4b70b4f9766f0a56dd2ecda31948b8cae33a9e00e532d0d42ded98333e33
cites cdi_FETCH-LOGICAL-c1121-18a5c4b70b4f9766f0a56dd2ecda31948b8cae33a9e00e532d0d42ded98333e33
container_end_page 188
container_issue 1
container_start_page 172
container_title Drugs and drug candidates
container_volume 2
creator El Boukhari, Reda
Fatimi, Ahmed
description We reviewed the patentability of rosemary-derived drugs and bioactive compounds over the last 20 years and analyzed patent documents related to the rosemary (Rosmarinus officinalis Linné) plant using patent analysis techniques. A total of 12,320 patent documents (patent applications and granted patents) were identified, with China having the highest number of patent documents at 4384. The year 2017 had the most patent documents (1122). Patent classification codes indicate that most inventions are for medicinal preparations and cosmetics characterized by their composition. Further, expert driving forces and knowledge clusters showed that research and development has focused on methods to bring pharmaceutical products into specific physical or administering forms, which are described in the majority of patents. To demonstrate the innovation trends in rosemary-derived drugs and bioactive compounds, a selection of relevant patent documents, with publication dates between 2002 and 2022, is described at the end of the study. This selection contains a total of 13 patent documents, including six patent applications and seven granted patents, and deals with pharmaceutical and biomedical applications, processes for extracting rosemary-derived biomolecules (e.g., rosmarinic acid, carnosic acid, and carnosol), and cosmetic and food applications.
doi_str_mv 10.3390/ddc2010011
format article
fullrecord <record><control><sourceid>crossref</sourceid><recordid>TN_cdi_crossref_primary_10_3390_ddc2010011</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>10_3390_ddc2010011</sourcerecordid><originalsourceid>FETCH-LOGICAL-c1121-18a5c4b70b4f9766f0a56dd2ecda31948b8cae33a9e00e532d0d42ded98333e33</originalsourceid><addsrcrecordid>eNpNkE9LAzEUxIMoWGovfoKchdWXvP2THGurVShUip6XbPJWI-2mJNtKv71dFPQ0w29gGIaxawG3iBrunLMSBIAQZ2wklcBMaq3O__lLNknpEwCkllgVesRWU76mg6cvHlrefxB_MT11vWn8xvfHAa5Doq2Jx2xO0R_I8XncvyduOsfvfTC2P0E-C9td2HcuXbGL1mwSTX51zN4eH15nT9lytXieTZeZFUKKTChT2LypoMlbXZVlC6YonZNknUGhc9UoawjRaAKgAqUDl0tHTitEPAVjdvPTa2NIKVJb76IfZtYC6uGN-u8N_AbV9FH7</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>A Review of the Patentability of Rosemary-Derived Drugs and Bioactive Compounds</title><source>Open Access: DOAJ - Directory of Open Access Journals</source><creator>El Boukhari, Reda ; Fatimi, Ahmed</creator><creatorcontrib>El Boukhari, Reda ; Fatimi, Ahmed</creatorcontrib><description>We reviewed the patentability of rosemary-derived drugs and bioactive compounds over the last 20 years and analyzed patent documents related to the rosemary (Rosmarinus officinalis Linné) plant using patent analysis techniques. A total of 12,320 patent documents (patent applications and granted patents) were identified, with China having the highest number of patent documents at 4384. The year 2017 had the most patent documents (1122). Patent classification codes indicate that most inventions are for medicinal preparations and cosmetics characterized by their composition. Further, expert driving forces and knowledge clusters showed that research and development has focused on methods to bring pharmaceutical products into specific physical or administering forms, which are described in the majority of patents. To demonstrate the innovation trends in rosemary-derived drugs and bioactive compounds, a selection of relevant patent documents, with publication dates between 2002 and 2022, is described at the end of the study. This selection contains a total of 13 patent documents, including six patent applications and seven granted patents, and deals with pharmaceutical and biomedical applications, processes for extracting rosemary-derived biomolecules (e.g., rosmarinic acid, carnosic acid, and carnosol), and cosmetic and food applications.</description><identifier>ISSN: 2813-2998</identifier><identifier>EISSN: 2813-2998</identifier><identifier>DOI: 10.3390/ddc2010011</identifier><language>eng</language><ispartof>Drugs and drug candidates, 2023-03, Vol.2 (1), p.172-188</ispartof><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c1121-18a5c4b70b4f9766f0a56dd2ecda31948b8cae33a9e00e532d0d42ded98333e33</citedby><cites>FETCH-LOGICAL-c1121-18a5c4b70b4f9766f0a56dd2ecda31948b8cae33a9e00e532d0d42ded98333e33</cites><orcidid>0000-0001-8749-2009 ; 0000-0002-4833-8540</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,864,27924,27925</link.rule.ids></links><search><creatorcontrib>El Boukhari, Reda</creatorcontrib><creatorcontrib>Fatimi, Ahmed</creatorcontrib><title>A Review of the Patentability of Rosemary-Derived Drugs and Bioactive Compounds</title><title>Drugs and drug candidates</title><description>We reviewed the patentability of rosemary-derived drugs and bioactive compounds over the last 20 years and analyzed patent documents related to the rosemary (Rosmarinus officinalis Linné) plant using patent analysis techniques. A total of 12,320 patent documents (patent applications and granted patents) were identified, with China having the highest number of patent documents at 4384. The year 2017 had the most patent documents (1122). Patent classification codes indicate that most inventions are for medicinal preparations and cosmetics characterized by their composition. Further, expert driving forces and knowledge clusters showed that research and development has focused on methods to bring pharmaceutical products into specific physical or administering forms, which are described in the majority of patents. To demonstrate the innovation trends in rosemary-derived drugs and bioactive compounds, a selection of relevant patent documents, with publication dates between 2002 and 2022, is described at the end of the study. This selection contains a total of 13 patent documents, including six patent applications and seven granted patents, and deals with pharmaceutical and biomedical applications, processes for extracting rosemary-derived biomolecules (e.g., rosmarinic acid, carnosic acid, and carnosol), and cosmetic and food applications.</description><issn>2813-2998</issn><issn>2813-2998</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNpNkE9LAzEUxIMoWGovfoKchdWXvP2THGurVShUip6XbPJWI-2mJNtKv71dFPQ0w29gGIaxawG3iBrunLMSBIAQZ2wklcBMaq3O__lLNknpEwCkllgVesRWU76mg6cvHlrefxB_MT11vWn8xvfHAa5Doq2Jx2xO0R_I8XncvyduOsfvfTC2P0E-C9td2HcuXbGL1mwSTX51zN4eH15nT9lytXieTZeZFUKKTChT2LypoMlbXZVlC6YonZNknUGhc9UoawjRaAKgAqUDl0tHTitEPAVjdvPTa2NIKVJb76IfZtYC6uGN-u8N_AbV9FH7</recordid><startdate>20230316</startdate><enddate>20230316</enddate><creator>El Boukhari, Reda</creator><creator>Fatimi, Ahmed</creator><scope>AAYXX</scope><scope>CITATION</scope><orcidid>https://orcid.org/0000-0001-8749-2009</orcidid><orcidid>https://orcid.org/0000-0002-4833-8540</orcidid></search><sort><creationdate>20230316</creationdate><title>A Review of the Patentability of Rosemary-Derived Drugs and Bioactive Compounds</title><author>El Boukhari, Reda ; Fatimi, Ahmed</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c1121-18a5c4b70b4f9766f0a56dd2ecda31948b8cae33a9e00e532d0d42ded98333e33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>online_resources</toplevel><creatorcontrib>El Boukhari, Reda</creatorcontrib><creatorcontrib>Fatimi, Ahmed</creatorcontrib><collection>CrossRef</collection><jtitle>Drugs and drug candidates</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>El Boukhari, Reda</au><au>Fatimi, Ahmed</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A Review of the Patentability of Rosemary-Derived Drugs and Bioactive Compounds</atitle><jtitle>Drugs and drug candidates</jtitle><date>2023-03-16</date><risdate>2023</risdate><volume>2</volume><issue>1</issue><spage>172</spage><epage>188</epage><pages>172-188</pages><issn>2813-2998</issn><eissn>2813-2998</eissn><abstract>We reviewed the patentability of rosemary-derived drugs and bioactive compounds over the last 20 years and analyzed patent documents related to the rosemary (Rosmarinus officinalis Linné) plant using patent analysis techniques. A total of 12,320 patent documents (patent applications and granted patents) were identified, with China having the highest number of patent documents at 4384. The year 2017 had the most patent documents (1122). Patent classification codes indicate that most inventions are for medicinal preparations and cosmetics characterized by their composition. Further, expert driving forces and knowledge clusters showed that research and development has focused on methods to bring pharmaceutical products into specific physical or administering forms, which are described in the majority of patents. To demonstrate the innovation trends in rosemary-derived drugs and bioactive compounds, a selection of relevant patent documents, with publication dates between 2002 and 2022, is described at the end of the study. This selection contains a total of 13 patent documents, including six patent applications and seven granted patents, and deals with pharmaceutical and biomedical applications, processes for extracting rosemary-derived biomolecules (e.g., rosmarinic acid, carnosic acid, and carnosol), and cosmetic and food applications.</abstract><doi>10.3390/ddc2010011</doi><tpages>17</tpages><orcidid>https://orcid.org/0000-0001-8749-2009</orcidid><orcidid>https://orcid.org/0000-0002-4833-8540</orcidid><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 2813-2998
ispartof Drugs and drug candidates, 2023-03, Vol.2 (1), p.172-188
issn 2813-2998
2813-2998
language eng
recordid cdi_crossref_primary_10_3390_ddc2010011
source Open Access: DOAJ - Directory of Open Access Journals
title A Review of the Patentability of Rosemary-Derived Drugs and Bioactive Compounds
url http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-06T05%3A41%3A13IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-crossref&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20Review%20of%20the%20Patentability%20of%20Rosemary-Derived%20Drugs%20and%20Bioactive%20Compounds&rft.jtitle=Drugs%20and%20drug%20candidates&rft.au=El%20Boukhari,%20Reda&rft.date=2023-03-16&rft.volume=2&rft.issue=1&rft.spage=172&rft.epage=188&rft.pages=172-188&rft.issn=2813-2998&rft.eissn=2813-2998&rft_id=info:doi/10.3390/ddc2010011&rft_dat=%3Ccrossref%3E10_3390_ddc2010011%3C/crossref%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c1121-18a5c4b70b4f9766f0a56dd2ecda31948b8cae33a9e00e532d0d42ded98333e33%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true